Variant report
Variant | esv2754176 |
---|---|
Chromosome Location | chr13:63358172-63449509 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:63305859..63307828-chr13:63368512..63371200,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PCDH20-4 | chr13:63368629-63368706 | NONHSAT034155 |
2 | lnc-PCDH20-4 | chr13:63370693-63370823 | XLOC_010638 |
3 | lnc-PCDH20-4 | chr13:63368629-63368704 | XLOC_010638 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000228669 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549565549 | chr13:63362818-63362819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547301948 | chr13:63362828-63362829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561689076 | chr13:63362848-63362849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528861300 | chr13:63362856-63362857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7319717 | chr13:63362858-63362859 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs566009974 | chr13:63362883-63362884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529508498 | chr13:63362891-63362892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539351841 | chr13:63362913-63362914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373930699 | chr13:63362950-63362951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188529753 | chr13:63362957-63362958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs74700125 | chr13:63362966-63362967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556352336 | chr13:63362980-63362981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376145547 | chr13:63362997-63362998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574505231 | chr13:63363012-63363013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145634548 | chr13:63363039-63363040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577423724 | chr13:63363059-63363060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373611933 | chr13:63363072-63363073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115889640 | chr13:63363083-63363084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6562295 | chr13:63363084-63363085 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs115113969 | chr13:63363086-63363087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75820770 | chr13:63363092-63363093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543520737 | chr13:63363106-63363107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561801177 | chr13:63363125-63363126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528977102 | chr13:63363171-63363172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77995797 | chr13:63363186-63363187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539659234 | chr13:63363232-63363233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111650407 | chr13:63363233-63363234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551337148 | chr13:63363236-63363237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181749724 | chr13:63363257-63363258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141224546 | chr13:63363297-63363298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9598500 | chr13:63363302-63363303 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs370328581 | chr13:63363324-63363325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373544826 | chr13:63363341-63363342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145006162 | chr13:63363372-63363373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568241753 | chr13:63363476-63363477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535549160 | chr13:63363503-63363504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553789978 | chr13:63363520-63363521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565696712 | chr13:63363531-63363532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112540811 | chr13:63363584-63363585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540147122 | chr13:63363592-63363593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116899958 | chr13:63363597-63363598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7325971 | chr13:63363653-63363654 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs370984980 | chr13:63363674-63363675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201701968 | chr13:63363677-63363678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9592214 | chr13:63363689-63363690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs202239673 | chr13:63363694-63363695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs201805700 | chr13:63363695-63363696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186778168 | chr13:63363722-63363723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113695468 | chr13:63363749-63363750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532761341 | chr13:63363777-63363778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:63362800-63363000 | Enhancers | Adipose Nuclei | Adipose |
2 | chr13:63363000-63366600 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr13:63366600-63367000 | Enhancers | Adipose Nuclei | Adipose |
4 | chr13:63373000-63373200 | Enhancers | Adipose Nuclei | Adipose |
5 | chr13:63373200-63374000 | Flanking Active TSS | Adipose Nuclei | Adipose |
6 | chr13:63373200-63375600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr13:63374000-63374200 | Active TSS | Adipose Nuclei | Adipose |
8 | chr13:63375000-63375200 | Enhancers | Adipose Nuclei | Adipose |
9 | chr13:63399800-63400200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:63400400-63401600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr13:63412000-63412200 | Enhancers | Hela-S3 | cervix |
12 | chr13:63413000-63413800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
13 | chr13:63420000-63421400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr13:63420600-63421000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr13:63427200-63428200 | Enhancers | Dnd41 | blood |
16 | chr13:63431800-63432200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr13:63431800-63432400 | Enhancers | Adipose Nuclei | Adipose |
18 | chr13:63449000-63449800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |